Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone plus tranexamic acid as tourniquet adjuvant in knee resurfacing arthroplasty
ChiCTR2100049449Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone and tranexamic acid in knee osteoarthritis (OA) (2 arms), sponsored by Xi'an Honghui Hospital. Primary endpoints: Tourniquet service time, Operation time and 12 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
dexamethasonetranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2100049449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049449.